Who Holds SAB Biotherapeutics, Inc. (SABS)? 87 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 87 holders, $267 million in total.
Largest holders
The 87 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Caligan Partners LP | 7,967,207 | $31 million | +0% | 13F |
| Vivo Capital, LLC | 7,299,909 | $28 million | -36% | 13F |
| PERCEPTIVE ADVISORS LLC | 6,627,501 | $26 million | +3% | 13F |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6,405,553 | $25 million | +88% | 13F |
| RA CAPITAL MANAGEMENT, L.P. | 4,401,500 | $17 million | +0% | 13F |
| Balyasny Asset Management L.P. | 3,760,439 | $15 million | +0% | 13F |
| BlackRock, Inc. | 3,066,016 | $12 million | +918% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,972,929 | $12 million | +19% | 13F |
| Commodore Capital LP | 2,870,000 | $11 million | -35% | 13F |
| MILLENNIUM MANAGEMENT LLC | 2,749,087 | $11 million | -9% | 13F |
| Spruce Street Capital LP | 2,198,502 | $9 million | +0% | 13F |
| Sessa Capital IM, L.P. | 2,198,457 | $9 million | +0% | 13F |
| Affinity Asset Advisors, LLC | 1,525,000 | $6 million | +165% | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,481,660 | $6 million | +0% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 1,277,185 | $5 million | +323% | 13F |
| Woodline Partners LP | 1,180,355 | $5 million | -59% | 13F |
| Ensign Peak Advisors, Inc | 1,172,641 | $5 million | -15% | 13F |
| Propel Bio Management, LLC | 1,076,578 | $4 million | +6% | 13F |
| Soleus Capital Management, L.P. | 900,000 | $4 million | -14% | 13F |
| Seven Fleet Capital Management LP | 736,077 | $3 million | +636% | 13F |
| AMERIPRISE FINANCIAL INC | 611,019 | $2 million | -59% | 13F |
| STATE STREET CORP | 530,831 | $2 million | +615% | 13F |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 438,515 | $2 million | New | 13F |
| DV EQUITIES, LLC | 400,000 | $2 million | New | 13F |
| AWM Investment Company, Inc. | 375,000 | $1 million | -6% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 373,980 | $1 million | +89% | 13F |
| UBS Group AG | 365,878 | $1 million | +685% | 13F |
| NORTHERN TRUST CORP | 362,489 | $1 million | +531% | 13F |
| STEMPOINT CAPITAL LP | 342,631 | $1 million | -9% | 13F |
| HB Wealth Management, LLC | 307,500 | $1 million | +0% | 13F |
| Polymer Capital Management (HK) LTD | 306,581 | $1 million | New | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 292,728 | $1 million | New | 13F |
| TWO SIGMA INVESTMENTS, LP | 214,632 | $837,065 | +18% | 13F |
| GOLDMAN SACHS GROUP INC | 191,305 | $746,089 | +68% | 13F |
| Bank of New York Mellon Corp | 107,847 | $420,604 | New | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 105,682 | $412,160 | New | 13F |
| Simplify Asset Management Inc. | 104,849 | $408,911 | -44% | 13F |
| AMERICAN CENTURY COMPANIES INC | 84,685 | $330,271 | +126% | 13F |
| ALPS ADVISORS INC | 77,600 | $302,640 | New | 13F |
| Stonepine Capital Management, LLC | 73,271 | $285,757 | +47% | 13F |
| CITADEL ADVISORS LLC | 62,797 | $244,908 | New | 13F |
| Nuveen, LLC | 58,398 | $227,752 | New | 13F |
| Pathstone Holdings, LLC | 50,650 | $197,537 | +0% | 13F |
| Kestra Advisory Services, LLC | 49,811 | $194,263 | -19% | 13F |
| RHUMBLINE ADVISERS | 45,164 | $176,133 | New | 13F |
| WELLS FARGO & COMPANY/MN | 44,083 | $171,924 | New | 13F |
| DEUTSCHE BANK AG\ | 42,371 | $165,247 | New | 13F |
| IFP Advisors, Inc | 38,699 | $150,926 | New | 13F |
| BARCLAYS PLC | 35,902 | $140,019 | +7138% | 13F |
| MetLife Investment Management, LLC | 28,015 | $109,259 | New | 13F |
| ALLIANCEBERNSTEIN L.P. | 26,970 | $105,183 | New | 13F |
| CITIGROUP INC | 26,584 | $103,677 | -28% | 13F |
| Persistent Asset Partners Ltd | 25,400 | $99,060 | -64% | 13F |
| BANK OF AMERICA CORP /DE/ | 25,126 | $97,991 | -55% | 13F |
| Invesco Ltd. | 22,593 | $88,112 | New | 13F |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 19,996 | $77,984 | New | 13F |
| JPMORGAN CHASE & CO | 18,089 | $70,547 | +20692% | 13F |
| Scientech Research LLC | 17,446 | $68,039 | +61% | 13F |
| Quadrature Capital Ltd | 15,195 | $59,261 | -57% | 13F |
| JANE STREET GROUP, LLC | 14,634 | $57,073 | New | 13F |
| MORGAN STANLEY | 13,750 | $53,624 | +15% | 13F |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 12,947 | $50,493 | New | 13F |
| NEW YORK STATE COMMON RETIREMENT FUND | 12,900 | $50,310 | New | 13F |
| Miller Capital Partners, Inc. | 12,870 | $50,193 | +0% | 13F |
| Police & Firemen's Retirement System of New Jersey | 12,807 | $49,947 | New | 13F |
| Vanguard Global Advisers, LLC | 11,852 | $46,223 | +0% | 13F |
| PNC Financial Services Group, Inc. | 10,270 | $40,053 | +33% | 13F |
| BNP PARIBAS FINANCIAL MARKETS | 8,633 | $33,669 | +871% | 13F |
| STRS OHIO | 8,500 | $33,150 | New | 13F |
| OSAIC HOLDINGS, INC. | 8,086 | $31,534 | +4% | 13F |
| Plante Moran Financial Advisors, LLC | 5,925 | $23,108 | +0% | 13F |
| Legal & General Group Plc | 4,223 | $16,470 | New | 13F |
| Ameritas Investment Partners, Inc. | 3,941 | $15,370 | New | 13F |
| Russell Investments Group, Ltd. | 3,472 | $13,540 | New | 13F |
| Tower Research Capital LLC (TRC) | 2,520 | $9,828 | -23% | 13F |
| Federation des caisses Desjardins du Quebec | 2,000 | $7,800 | New | 13F |
| GROUP ONE TRADING LLC | 1,852 | $7,223 | New | 13F |
| ROYAL BANK OF CANADA | 1,687 | $7,000 | +168600% | 13F |
| Truvestments Capital LLC | 1,100 | $4,290 | New | 13F |
| Sterling Capital Management LLC | 875 | $3,413 | New | 13F |
| Caitong International Asset Management Co., Ltd | 742 | $2,894 | +361% | 13F |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 598 | $2,332 | New | 13F |
| GS Investments, Inc. | 200 | $780 | +0% | 13F |
| FMR LLC | 116 | $452 | New | 13F |
| HARBOUR INVESTMENTS, INC. | 50 | $195 | +0% | 13F |
| PRICE T ROWE ASSOCIATES INC /MD/ | 35,620 | $139 | New | 13F |
| First PREMIER Bank | 18,986 | $74 | +0% | 13F |
Questions and answers
- How many institutions hold SAB Biotherapeutics, Inc.?
- 87 managers reported SAB Biotherapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 76 the quarter before.
- Who is the largest institutional holder of SAB Biotherapeutics, Inc.?
- Caligan Partners LP, with 7,967,207 shares worth $31 million on its 13F for Q2 2026.
- How many institutions bought or sold out of SAB Biotherapeutics, Inc. in Q2 2026?
- 32 managers reported a new position and 21 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds SAB Biotherapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/biotherapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.